Where does Arcus Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arcus Biosciences, Inc. ranks #9,436 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arcus Biosciences, Inc. hold?

Arcus Biosciences, Inc. holds 33 US utility patents granted between 2019 and 2025, spanning 11 technology areas.

What is Arcus Biosciences, Inc.'s Innovation Score?

Arcus Biosciences, Inc. has an Innovation Score of 54.6 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arcus Biosciences, Inc. focus on?

Arcus Biosciences, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 29 patents, ranking #678 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Arcus Biosciences, Inc.'s patent grant rate increasing or decreasing?

Arcus Biosciences, Inc.'s recent grant velocity is +1050% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Arcus Biosciences, Inc.'s patents?

Arcus Biosciences, Inc.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arcus Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arcus Biosciences, Inc.

USPTO PatentsView assignee record - 33 granted patents across 11 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arcus ranks #9,436 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 11 technology areas.

#9,436
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.6/100): 17.8
avg claims per patent: +1050%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9436 · US Corporation #9,436 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,436/49,997
PHOTO-FINISH Altia Systems
CPC-FOCUS A61P · 11 areas
INNOV-PAR 54.6/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1050% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Altia Systems Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arcus’s 54.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (22%) Velocity 20.0 pts (37%) Breadth 11.7 pts (21%) Claim depth 10.7 pts (20%)

Qualcomm Incorporated · highest

85
Anhui Agricultural… · near

55
Arcus Biosciences · this assignee

55
Bambino Prezioso… · near

55
Institut National… · near

55
Karlsruher Institut… · near

55
3D Lighting… · lowest

7

What this shows Arcus's Innovation Score is 54.6/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arcus?

Each dot is one of Arcus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arcus’s own 17.8 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arcus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arcus's grants concentrate

Arcus Biosciences, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 87.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (9 grants) versus a trough of 2 in 2019. By volume, Arcus sits between Altia Systems Inc and Ayla Networks, Inc..

Arcus's three-year grant acceleration

Arcus Biosciences, Inc. shows 19 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Altia Systems

33
Appdynamics

33
Aragon Pharmaceut…

33
Arcelormittal Fra…

33
Astora Women's He…

33
Atlas Spine

33
Axopar Holdings Oy

33
Ayla Networks

33
Arcus Biosciences ◀

33

What this shows Arcus holds 33 patents at rank #9,437, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arcus

By rank, the assignees closest to #9,437 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Arcus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arcus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Arcus ranks #678 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (55 here).

Anhui Agricultural University 55 Bambino Prezioso Switzerland 55 Institut National D'optique 55 Karlsruher Institut FÜR Technologie 55

Arcus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Arcus Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	6.1%
2021	4	12.1%
2022	4	12.1%
2023	6	18.2%
2024	9	27.3%
2025partial year	8	24.2%

Which technologies does Arcus Biosciences, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 29

C07D - Heterocyclic Compounds 20

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 7

C07K - Peptides 6

C07C - Acyclic OR Carbocyclic Compounds 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arcus Biosciences, Inc.'s patent record in context - here's where to go next.

Arcus Biosciences, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 87.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,436 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arcus Biosciences, Inc. against Altia Systems Inc, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.